Elucidata

Enhance drug discovery by leveraging generative AI and machine learning foundation models, utilizing AI-ready multimodal data and scalable harmonization

Elucidata's Polly platform uses AI-powered workflows to automate data ingestion, optimize resources, and support core facility data management and research.

The page says ML-ready omics data helps translational researchers discover and validate biomarkers 75% faster, classify markers, and ensure clinical relevance.

Elucidata's Polly platform automates data pipelines for scalable, production-ready cloud diagnostics workflows, reduces costs, and accelerates biopharma research from omics data to insights.

The fireside chat discusses the pros and cons of large and small models in drug discovery and AI applications.

The page outlines reasons to switch to El-Maven, an open-source LC-MS data processing engine for metabolomics analysis.

The page explains why a standard metadata file is important and how to create one.

The page says approval numbers dip slightly, while modalities ranging from Adnectins to non-opioid painkillers signal a new era of high-barrier therapeutics.

Elucidata seeks individuals across specializations who can work from anywhere.

The page introduces Elucidata's leadership team and its mission to help life sciences organizations address complex data challenges through tailored scientific solutions and accelerate drug discovery.

The page describes a multidisciplinary team that provides life sciences organizations with tailored, end-to-end scientific and data solutions to address complex challenges and accelerate drug discovery.

The page features industry spotlights on insights, innovations, and applications in drug discovery and biomedical research.

Elucidata empowers life sciences teams to make more confident decisions across drug discovery, helping improve patient outcomes.

Elucidata helps pharma and biotech teams turn fragmented biological data into high-quality, structured systems - accelerating biomarker discovery, advancing target identification, and driving real progress in drug development.

The company's Privacy Policy explains what information it collects and why.